Pelletier G
Oncology and Molecular Endocrinology Research Center, Laval University Hospital and Laval University, Québec, Canada.
Histol Histopathol. 2000 Oct;15(4):1261-70. doi: 10.14670/HH-15.1261.
There is now evidence that estrogens and androgens are exerting their effects in different tissues throughout the body. In order to determine the sites of action of these steroids, studies have been performed to identify at the cellular level the localization of androgen receptor (AR) and the two estrogen receptor (ER) subtypes, ERalpha and ERbeta, specially in the rat, monkey and human. In the prostate, AR was observed in the secretory and stromal cells. In the testis, Sertoli, Leydig and myoid cells were labelled. In the epididymis and seminal vesicles, both epithelial and stromal cells contained AR. In the ovary, AR was detected in granulosa and interstitial cells. In the uterus, epithelial, stromal and muscle cells were all immunopositive for AR. In the central nervous system, AR-containing neurons were found to be widely distributed throughout the brain. In the mammary gland, epithelial cells in acini and ducts and stromal cells were demonstrated to express AR. In the skin, AR was detected in keratinocytes, sebaceous and sweat glands, and hair follicles. In addition, AR was also found in anterior pituitary, thyroid, adrenal cortex, liver, kidney tubules, urinary bladder, cardiac and striated muscle, and bone. The ER subtypes are in general differentially expressed. While ERalpha has been predominantly found in anterior pituitary, uterus, vagina, testis, liver and kidney, ERbeta is predominant in thyroid, ovary, prostate, skin, bladder, lungs, gastro-intestinal tract, cartilage and bone. In tissues which contain both receptor subtypes, such as ovary, testis and various regions of the brain, a cell-specific localization for each ER subtype has been generally observed. Altogether, the recent results on the cellular localization of sex steroid receptors will certainly contribute to a better understanding of the specific role of these steroids in different target organs.
现在有证据表明,雌激素和雄激素在全身不同组织中发挥作用。为了确定这些类固醇的作用位点,已经开展了研究,以在细胞水平上鉴定雄激素受体(AR)以及两种雌激素受体(ER)亚型,即ERα和ERβ的定位,特别是在大鼠、猴子和人类中的定位。在前列腺中,在分泌细胞和基质细胞中观察到AR。在睾丸中,支持细胞、间质细胞和肌样细胞被标记。在附睾和精囊中,上皮细胞和基质细胞都含有AR。在卵巢中,在颗粒细胞和间质细胞中检测到AR。在子宫中,上皮细胞、基质细胞和肌肉细胞对AR均呈免疫阳性。在中枢神经系统中,发现含AR的神经元广泛分布于整个大脑。在乳腺中,腺泡和导管中的上皮细胞以及基质细胞被证明表达AR。在皮肤中,在角质形成细胞、皮脂腺、汗腺和毛囊中检测到AR。此外,在前脑垂体、甲状腺、肾上腺皮质、肝脏、肾小管、膀胱、心脏和横纹肌以及骨骼中也发现了AR。ER亚型通常存在差异表达。虽然ERα主要存在于前脑垂体、子宫、阴道、睾丸、肝脏和肾脏中,但ERβ主要存在于甲状腺、卵巢、前列腺、皮肤、膀胱、肺、胃肠道、软骨和骨骼中。在同时含有两种受体亚型的组织中,如卵巢、睾丸和大脑的各个区域,通常观察到每种ER亚型的细胞特异性定位。总之,关于性类固醇受体细胞定位的最新研究结果肯定有助于更好地理解这些类固醇在不同靶器官中的具体作用。